HOME >> BIOLOGY >> NEWS
The building blocks of erection: Nitric oxide...and more nitric oxide

A team of Hopkins scientists has greatly advanced the science of penile erection, showing for the first time the mechanism for continued production of nitric oxide that maintains an erection over time. The findings are published in the March 19 issue of the Proceedings of the National Academy of Sciences.

"The physiology of erection is like driving a car," says Arthur Burnett, M.D., associate professor of urology at Hopkins and senior author of the study. "You can't just turn the key and expect to go anywhere. You also need to hit and hold the accelerator."

Researchers at Hopkins ten years ago discovered that release of nitric oxide from nerve endings in the penis caused erection, but the temporary release of nitric oxide a neurotransmitter that survives just a few seconds before breaking down couldn't explain how erections are naturally sustained over time.

Working with rats and genetically transformed mice, Hopkins scientists found that after an initial burst of nitric oxide from nerve endings triggers erection, blood vessels release more nitric oxide to harden and maintain the erection.

"Once blood starts flowing into the penis, the source of nitric oxide in the blood vessels is continuously activated so that more nitric oxide is released, more tissue relaxes, more blood comes in and a sustained erection is achieved," Burnett says.

This cascade of events, Burnett says, begins when erotic thoughts or physical sensations produce nitric oxide release in nerve endings in the penis. Nitric oxide is a relaxant that allows blood vessels to open up or dilate, bringing increased blood flow and swelling of tissues. The flow of blood also creates a minor stress on the blood vessel wall which activates the release of more nitric oxide. This time it is from cells in the wall of the blood vessel the endothelial cells rather than from nerves. Endothelial nitric oxide causes more tissue to relax and the process repeats until
'"/>

Contact: Trent Stockton
tstockt1@jhmi.edu
410-955-8665
Johns Hopkins Medical Institutions
18-Mar-2002


Page: 1 2

Related biology news :

1. Termites could hold the key to self-sufficient buildings
2. Environmental costs of home construction lower with wise choice, reuse of building materials
3. Researchers show how to assemble building blocks for nanotechnology
4. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
5. Near-zero-energy buildings blessing to owners, environment
6. RNA could form building blocks for nanomachines
7. Indoor mold, building dampness linked to respiratory problems and require better prevention
8. New IU Bloomington life sciences building gets a name
9. Purdue chemists put the twist on protein building block
10. Destructive wizardry of Ozz-E3 ligase appears key to building skeletal muscles in embryos and adults
11. Swimming can contribute to rebuilding bone strength

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/4/2019)... ... January 03, 2019 , ... Over the ... into their drug discovery research workflows with biology ranging from single cell-type spheroids ... of in vitro studies, they create several challenges that need to be overcome ...
(Date:12/27/2018)... FRANCISCO (PRWEB) , ... December 27, 2018 , ... ... annual Microbiome Conference at JPM as part of the JP Morgan 37th Annual ... innovative scientists and physicians, and members of the investment community. , Since ...
(Date:12/20/2018)... ... December 20, 2018 , ... Human Factors and product ... a new usability/observation room. This addition will help meet the increased industry demand ... delivery devices/combination products are safe and easy to use when released to the ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... Fla. (PRWEB) , ... January ... ... Geometrical Implant Co, (SAGICO), an innovative spinal implant company, announced today that ... in San Francisco, California. The annual J.P. Morgan Healthcare Conference is ...
(Date:1/7/2019)... SEONGNAM, South Korea (PRWEB) , ... January 07, ... ... has completed Phase 1 clinical trials of its Parkinson's Disease drug candidate, code-named ... disease-modifying treatment of Parkinson's Disease. The trial took place in South Korea. ...
(Date:1/4/2019)... ... January 03, 2019 , ... Calidi Biotherapeutics, Inc., ... today announced the founding of a scientific and medical advisory board (SMAB). The ... leaders in the Immuno-Oncology field. The founding members of Calidi Biotherapeutics SMAB include ...
(Date:12/18/2018)... ... December 17, 2018 , ... ABCT ... emerging biosciences ventures invited to participate in the annual program. Twelve ventures will ... plans and a professional network. All startups receive an entrepreneur coach, access to ...
Breaking Biology Technology:
Cached News: